Related Experiment Video
Updated: Mar 16, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Chronic hepatitis E - an emerging disease in an immunocompromised host
Amitabh Singh1, Rachna Seth1, Anand Gupta1
1Department of Paediatrics, All India Institute of Medical Sciences, New Delhi, India.
Chronic hepatitis E virus (HEV) infection is a growing concern in immunocompromised patients. Ribavirin effectively eradicates HEV infection, improving survival in these vulnerable individuals.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatitis E virus (HEV) infection is increasingly diagnosed in immunosuppressed populations, including those with HIV, hematological malignancies, and transplant recipients.
- Diagnostic criteria for cirrhosis and liver failure in chronic HEV remain controversial.
- Limited data exist on the efficacy of ribavirin for treating genotype 1 chronic HEV.
Observation:
- A case of chronic HEV genotype 1 infection causing chronic liver disease in a child with a history of acute leukemia is presented.
- This case highlights the challenges in diagnosing and managing chronic HEV in specific patient groups.
Findings:
- Successful eradication of chronic HEV infection was achieved using ribavirin.
- Ribavirin treatment demonstrated subsequent survival benefits in the patient.
- Chronic hepatitis E should be considered in immunosuppressed patients with unexplained elevated liver enzymes (cryptogenic transaminitis).
Implications:
- Chronic hepatitis E may represent an emerging disease in immunocompromised individuals.
- Ribavirin is confirmed as an effective therapeutic agent for controlling HEV infection.
- Early suspicion and treatment of chronic HEV are crucial for improving outcomes in at-risk populations.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

